Literature DB >> 27073467

miR-133b, a microRNA targeting S1PR1, suppresses nasopharyngeal carcinoma cell proliferation.

Nan Cheng1, Guang-Hui Wang1.   

Abstract

MicroRNAs (miRs) are a class of short and non-coding RNA molecules, which function as either oncogenes or tumor suppressors in the development of various human cancers, including nasopharyngeal carcinoma (NPC). The aim of the present study was to investigate the expression of miR-133b in NPC tissue samples, as compared with adjacent normal tissues, and to examine its roles and underlying mechanisms. Analysis using reverse transcription-quantitative polymerase chain reaction demonstrated that miR-133b was downregulated in NPC tissue samples, as compared with adjacent tissues. In vitro experiments using NPC cell lines transfected with miR-133b mimics or antisense oligonucleotides further demonstrated that the overexpression of miR-133b mimics impaired, whereas knockdown of its expression promoted, the proliferation of NPC cells. Sphingosine-1-phosphate receptor 1 (S1PR1) was predicted to be a target of miR-133b. Luciferase reporter assays showed that miR-133b inhibited the protein expression of S1PR1 by targeting its 3'-untranslated region. Furthermore, western blot analysis demonstrated that miR-133B altered the regulation of the signal transducer and activator of transcription-3 (STAT3) signaling pathway and the expression of downstream proteins in NPC cells. Therefore, the results of the present study suggested that a previously unknown miR-133b/S1PR1 molecular network may regulate NPC progression.

Entities:  

Keywords:  miR-133b; microRNA; nasopharyngeal carcinoma; sphingosine-1-phosphate receptor 1

Year:  2016        PMID: 27073467      PMCID: PMC4812514          DOI: 10.3892/etm.2016.3043

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  24 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  MicroRNAs: potential diagnostic markers and therapeutic targets for EBV-associated nasopharyngeal carcinoma.

Authors:  Ming-Liang He; Millore X-M Luo; Marie C Lin; Hsiang-fu Kung
Journal:  Biochim Biophys Acta       Date:  2011-09-17

3.  S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites.

Authors:  Jiehui Deng; Yong Liu; Heehyoung Lee; Andreas Herrmann; Wang Zhang; Chunyan Zhang; Shudan Shen; Saul J Priceman; Maciej Kujawski; Sumanta K Pal; Andrew Raubitschek; Dave S B Hoon; Stephen Forman; Robert A Figlin; Jie Liu; Richard Jove; Hua Yu
Journal:  Cancer Cell       Date:  2012-05-15       Impact factor: 31.743

4.  Serum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcoma.

Authors:  Chun Zhang; Cong Yao; Haopeng Li; Guoyu Wang; Xijing He
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

5.  MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer.

Authors:  Tianzhu Qiu; Xin Zhou; Jian Wang; Yiping Du; Jun Xu; Zebo Huang; Wei Zhu; Yongqian Shu; Ping Liu
Journal:  FEBS Lett       Date:  2014-03-05       Impact factor: 4.124

6.  Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer.

Authors:  Jie Liang; Masayuki Nagahashi; Eugene Y Kim; Kuzhuvelil B Harikumar; Akimitsu Yamada; Wei-Ching Huang; Nitai C Hait; Jeremy C Allegood; Megan M Price; Dorit Avni; Kazuaki Takabe; Tomasz Kordula; Sheldon Milstien; Sarah Spiegel
Journal:  Cancer Cell       Date:  2012-12-27       Impact factor: 31.743

7.  MiR-133b acts as a tumor suppressor and negatively regulates TBPL1 in colorectal cancer cells.

Authors:  Kai-Min Xiang; Xiao-Rong Li
Journal:  Asian Pac J Cancer Prev       Date:  2014

Review 8.  Epstein-Barr virus antibodies and the risk of associated malignancies: review of the literature.

Authors:  Anna E Coghill; Allan Hildesheim
Journal:  Am J Epidemiol       Date:  2014-08-28       Impact factor: 4.897

9.  STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors.

Authors:  Heehyoung Lee; Jiehui Deng; Maciej Kujawski; Chunmei Yang; Yong Liu; Andreas Herrmann; Marcin Kortylewski; David Horne; George Somlo; Stephen Forman; Richard Jove; Hua Yu
Journal:  Nat Med       Date:  2010-11-21       Impact factor: 53.440

10.  Knockdown of miR-214 promotes apoptosis and inhibits cell proliferation in nasopharyngeal carcinoma.

Authors:  Zi-Chen Zhang; Yang-Yang Li; Hai-Yun Wang; Sha Fu; Xiao-Pai Wang; Mu-Sheng Zeng; Yi-Xin Zeng; Jian-Yong Shao
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

View more
  10 in total

1.  Human umbilical cord mesenchymal stem cell-derived exosome-mediated transfer of microRNA-133b boosts trophoblast cell proliferation, migration and invasion in preeclampsia by restricting SGK1.

Authors:  Dan Wang; Quan Na; Gui Yu Song; Leilei Wang
Journal:  Cell Cycle       Date:  2020-06-28       Impact factor: 4.534

2.  SP1-induced AFAP1-AS1 contributes to proliferation and invasion by regulating miR-497-5p/CELF1 pathway in nasopharyngeal carcinoma.

Authors:  Hui Jin; Gengtian Liang; Liping Yang; Li Liu; Binru Wang; Fengqin Yan
Journal:  Hum Cell       Date:  2021-01-05       Impact factor: 4.174

Review 3.  S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy.

Authors:  Narges Rostami; Afshin Nikkhoo; Amir Ajjoolabady; Gholamreza Azizi; Mohammad Hojjat-Farsangi; Ghasem Ghalamfarsa; Bahman Yousefi; Mehdi Yousefi; Farhad Jadidi-Niaragh
Journal:  Mol Diagn Ther       Date:  2019-08       Impact factor: 4.074

4.  Preclinical study of the antitumor effect of sphingosine-1-phosphate receptor 1 antibody (S1PR1-antibody) against human breast cancer cells.

Authors:  Shujun Xiao; Jian Yang
Journal:  Invest New Drugs       Date:  2018-06-02       Impact factor: 3.850

Review 5.  Lysolipids in Vascular Development, Biology, and Disease.

Authors:  Eric Engelbrecht; Calum A MacRae; Timothy Hla
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-17       Impact factor: 8.311

6.  Expression levels of plasma exosomal miR-124, miR-125b, miR-133b, miR-130a and miR-125b-1-3p in severe asthma patients and normal individuals with emphasis on inflammatory factors.

Authors:  Mostafa Atashbasteh; Esmaeil Mortaz; Seyed Alireza Mahdaviani; Hamidreza Jamaati; Abdolamir Allameh
Journal:  Allergy Asthma Clin Immunol       Date:  2021-05-17       Impact factor: 3.406

7.  MiR-130a-3p inhibits the viability, proliferation, invasion, and cell cycle, and promotes apoptosis of nasopharyngeal carcinoma cells by suppressing BACH2 expression.

Authors:  Xin Chen; Bo Yue; Changming Zhang; Meihao Qi; Jianhua Qiu; Ye Wang; Jun Chen
Journal:  Biosci Rep       Date:  2017-06-08       Impact factor: 3.840

Review 8.  miR-133b, a particular member of myomiRs, coming into playing its unique pathological role in human cancer.

Authors:  Daojiang Li; Lu Xia; Miao Chen; Changwei Lin; Hao Wu; Yi Zhang; Songqing Pan; Xiaorong Li
Journal:  Oncotarget       Date:  2017-07-25

Review 9.  Role of Sphingosine-1-Phosphate in Mast Cell Functions and Asthma and Its Regulation by Non-Coding RNA.

Authors:  Rohit Saluja; Ashok Kumar; Manju Jain; Sudhir K Goel; Aklank Jain
Journal:  Front Immunol       Date:  2017-05-22       Impact factor: 7.561

Review 10.  Interaction of microRNAs with sphingosine kinases, sphingosine-1 phosphate, and sphingosine-1 phosphate receptors in cancer.

Authors:  Guangmeng Xu; Zecheng Yang; Yamin Sun; Hongmei Dong; Jingru Ma
Journal:  Discov Oncol       Date:  2021-09-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.